1. A Cytosolic Multiprotein Complex Containing p85α Is Required for β-Catenin Activation in Colitis and Colitis-associated Cancer
- Author
-
Tianyan Gao, Linheng Li, Tatiana Goretsky, Hyunji Ryu, Mary Pat Moyer, Emily M. Bradford, Terrence A. Barrett, and Maryam Tahir
- Subjects
0301 basic medicine ,Beta-catenin ,Mice, Transgenic ,medicine.disease_cause ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,medicine ,Animals ,Humans ,Colitis ,Molecular Biology ,Protein kinase B ,PI3K/AKT/mTOR pathway ,beta Catenin ,biology ,Chemistry ,Azoxymethane ,Wnt signaling pathway ,food and beverages ,Molecular Bases of Disease ,Cell Biology ,medicine.disease ,Neoplasm Proteins ,Class Ia Phosphatidylinositol 3-Kinase ,030104 developmental biology ,030220 oncology & carcinogenesis ,Catenin ,Multiprotein Complexes ,Immunology ,Colonic Neoplasms ,biology.protein ,Cancer research ,Carcinogenesis ,Signal Transduction - Abstract
Wnt/β-catenin signaling is required for crypt structure maintenance. We previously observed nuclear accumulation of Ser-552 phosphorylated β-catenin (pβ-Cat(Ser-552)) in intestinal epithelial cells (IEC) during colitis and colitis-associated cancer. Data here delineate a novel multiprotein cytosolic complex (MCC) involved in β-catenin signaling in the intestine. The MCC contains p85α, the class IA subunit of PI3K, along with β-catenin, 14-3-3ζ, Akt, and p110α. MCC levels in IEC increase in colitis and colitis-associated cancer patients. IEC-specific p85α-deficient (p85(ΔIEC)) mice develop more severe dextran sodium sulfate colitis due to delayed ulcer healing and reduced epithelial β-catenin activation. In colonic IEC, p85α deficiency did not alter PI3K signaling. In vitro shRNA depletion of individual complex members disrupts the MCC and reduces β-catenin signaling. Despite worse colitis, p85(ΔIEC) mice have reduced tumor burden after azoxymethane/dextran sodium sulfate treatment. Together the data indicate that the β-catenin MCC is needed for mucosal repair and carcinogenesis. This novel MCC may be an attractive therapeutic target in preventing cancer in colitis patients.
- Published
- 2015